Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 2/2012

01-02-2012 | Original Research Article

Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by Age

Pooled Analysis of Two Open-Label Extension Studies

Published in: Drugs & Aging | Issue 2/2012

Login to get access
Metadata
Title
Long-Term Safety, Tolerability and Efficacy of Fesoterodine in Subjects with Overactive Bladder Symptoms Stratified by Age
Pooled Analysis of Two Open-Label Extension Studies
Publication date
01-02-2012
Published in
Drugs & Aging / Issue 2/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/11597970-000000000-00000

Other articles of this Issue 2/2012

Drugs & Aging 2/2012 Go to the issue

Review Article

Drug-Induced Parkinsonism in the Elderly

Review Article

Under-Prescribing and Non-Adherence to Medications after Coronary Bypass Surgery in Older Adults

Original Research Article

Potentially Inappropriate Prescribing in Older People with Dementia in Care Homes

Current Opinion

Possibility of a New Anti-Alzheimer’s Disease Pharmaceutical Composition Combining Memantine and Vitamin D

Original Research Article

Associations between Drug Burden Index and Mortality in Older People in Residential Aged Care Facilities

Original Research Article

RETRACTED ARTICLE: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits